Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer??s Disease
- 1 January 2002
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 16 (7) , 435-444
- https://doi.org/10.2165/00023210-200216070-00001
Abstract
This paper focuses on hypertension and hypercholesterolaemia as risk factors for Alzheimer’s disease and, as such, subjects for prevention. The long-term, prospective, population-based studies...Keywords
This publication has 49 references indexed in Scilit:
- A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's DiseaseNeurobiology of Disease, 2001
- Antihypertensive drugs and incidence of dementia: the Rotterdam StudyNeurobiology of Aging, 2001
- The Relationship Between Cholesterol and StrokeDrugs & Aging, 2000
- Vascular risk factors for Alzheimer’s disease:Neurobiology of Aging, 2000
- The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's diseaseBrain Research Reviews, 1998
- Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid?Journal of Human Hypertension, 1997
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- Effects of treatment with lovastatin and pravastatin on daytime cognitive performanceClinical Cardiology, 1995
- Central Nervous System Effects of HMG CoA Reductase Inhibitors: Lovastatin and Pravastatin on Sleep and Cognitive Performance in Patients with HypercholesterolemiaThe Journal of Clinical Pharmacology, 1994
- Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performanceClinical Cardiology, 1992